APO RESEARCH · REPORT
Human Organs-on-Chips
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Product & engineering
Understand the product.
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Selected research
Market Structure
Global Human Organs-on-Chips Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Read the full market overview
Global key players of Human Organs-on-Chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems and Draper Laboratory, etc. Top five players occupy for a share about 46%. North America is the largest market, with a share about 42%, followed by Asia-Pacific and Europe. In terms of product, Liver-on-a-chip is the largest segment, with a share over 28%. In terms of End User, Academic & Research Institutes is the largest market, with a share over 40%.
This report provides an overview of the global Human Organs-on-Chips market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Human Organs-on-Chips and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Human Organs-on-Chips sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Organs-on-Chips market size, projected growth trends, production technologies, key applications, and end-use industries.
Human Organs-on-Chips Segment by Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Human Organs-on-Chips Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Human Organs-on-Chips Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Human Organs-on-Chips Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Organs-on-Chips market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Organs-on-Chips and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Organs-on-Chips.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Organs-on-Chips market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Organs-on-Chips manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Organs-on-Chips in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Organs-on-Chips in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Vessel-on-a-chip
- Other Organs
Applications
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Cosmetics Industry
- Others
Companies covered
- Emulate
- TissUse
- Hesperos
- CN Bio Innovations
- Tara Biosystems
- Draper Laboratory
- Mimetas
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Human Organs-on-Chips Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Human Organs-on-Chips Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Human Organs-on-Chips Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Human Organs-on-Chips Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Human Organs-on-Chips Market Dynamics
- 2.1 Human Organs-on-Chips Industry Trends
- 2.2 Human Organs-on-Chips Industry Drivers
- 2.3 Human Organs-on-Chips Industry Opportunities and Challenges
- 2.4 Human Organs-on-Chips Industry Restraints
3 Human Organs-on-Chips Market by Manufacturers
- 3.1 Global Human Organs-on-Chips Revenue by Manufacturers (2021-2026)
- 3.2 Global Human Organs-on-Chips Sales by Manufacturers (2021-2026)
- 3.3 Global Human Organs-on-Chips Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Human Organs-on-Chips Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Human Organs-on-Chips Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Human Organs-on-Chips Manufacturers, Product Type & Application
- 3.7 Global Human Organs-on-Chips Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Human Organs-on-Chips Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Human Organs-on-Chips Players Market Share by Revenue in 2025
- 3.8.3 2025 Human Organs-on-Chips Tier 1, Tier 2, and Tier 3
4 Human Organs-on-Chips Market by Type
- 4.1 Human Organs-on-Chips Type Introduction
- 4.1.1 Brain-on-a-chip
- 4.1.2 Liver-on-a-chip
- 4.1.3 Kidney-on-a-chip
- 4.1.4 Lung-on-a-chip
- 4.1.5 Heart-on-a-chip
- 4.1.6 Intestine-on-a-chip
- 4.1.7 Vessel-on-a-chip
- 4.1.8 Other Organs
- 4.2 Global Human Organs-on-Chips Sales by Type
- 4.2.1 Global Human Organs-on-Chips Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Human Organs-on-Chips Sales by Type (2021-2032)
- 4.2.3 Global Human Organs-on-Chips Sales Market Share by Type (2021-2032)
- 4.3 Global Human Organs-on-Chips Revenue by Type
- 4.3.1 Global Human Organs-on-Chips Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Human Organs-on-Chips Revenue by Type (2021-2032)
- 4.3.3 Global Human Organs-on-Chips Revenue Market Share by Type (2021-2032)
5 Human Organs-on-Chips Market by Application
- 5.1 Human Organs-on-Chips Application Introduction
- 5.1.1 Pharmaceutical & Biotechnology Companies
- 5.1.2 Academic & Research Institutes
- 5.1.3 Cosmetics Industry
- 5.1.4 Others
- 5.2 Global Human Organs-on-Chips Sales by Application
- 5.2.1 Global Human Organs-on-Chips Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Human Organs-on-Chips Sales by Application (2021-2032)
- 5.2.3 Global Human Organs-on-Chips Sales Market Share by Application (2021-2032)
- 5.3 Global Human Organs-on-Chips Revenue by Application
- 5.3.1 Global Human Organs-on-Chips Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Human Organs-on-Chips Revenue by Application (2021-2032)
- 5.3.3 Global Human Organs-on-Chips Revenue Market Share by Application (2021-2032)
6 Global Human Organs-on-Chips Sales by Region
- 6.1 Global Human Organs-on-Chips Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Human Organs-on-Chips Sales by Region (2021-2032)
- 6.2.1 Global Human Organs-on-Chips Sales by Region (2021-2026)
- 6.2.2 Global Human Organs-on-Chips Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Human Organs-on-Chips Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Human Organs-on-Chips Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Human Organs-on-Chips Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Human Organs-on-Chips Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Human Organs-on-Chips Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Human Organs-on-Chips Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Human Organs-on-Chips Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Human Organs-on-Chips Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Human Organs-on-Chips Revenue by Region
- 7.1 Global Human Organs-on-Chips Revenue by Region
- 7.1.1 Global Human Organs-on-Chips Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Human Organs-on-Chips Revenue by Region (2021-2026)
- 7.1.3 Global Human Organs-on-Chips Revenue by Region (2027-2032)
- 7.1.4 Global Human Organs-on-Chips Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Human Organs-on-Chips Revenue (2021-2032)
- 7.2.2 North America Human Organs-on-Chips Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Human Organs-on-Chips Revenue (2021-2032)
- 7.3.2 Europe Human Organs-on-Chips Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Human Organs-on-Chips Revenue (2021-2032)
- 7.4.2 Asia-Pacific Human Organs-on-Chips Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Human Organs-on-Chips Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Human Organs-on-Chips Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Emulate
- 8.1.1 Emulate Company Information
- 8.1.2 Emulate Business Overview
- 8.1.3 Emulate Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Emulate Human Organs-on-Chips Product Portfolio
- 8.1.5 Emulate Recent Developments
- 8.2 TissUse
- 8.2.1 TissUse Company Information
- 8.2.2 TissUse Business Overview
- 8.2.3 TissUse Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 TissUse Human Organs-on-Chips Product Portfolio
- 8.2.5 TissUse Recent Developments
- 8.3 Hesperos
- 8.3.1 Hesperos Company Information
- 8.3.2 Hesperos Business Overview
- 8.3.3 Hesperos Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hesperos Human Organs-on-Chips Product Portfolio
- 8.3.5 Hesperos Recent Developments
- 8.4 CN Bio Innovations
- 8.4.1 CN Bio Innovations Company Information
- 8.4.2 CN Bio Innovations Business Overview
- 8.4.3 CN Bio Innovations Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 CN Bio Innovations Human Organs-on-Chips Product Portfolio
- 8.4.5 CN Bio Innovations Recent Developments
- 8.5 Tara Biosystems
- 8.5.1 Tara Biosystems Company Information
- 8.5.2 Tara Biosystems Business Overview
- 8.5.3 Tara Biosystems Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Tara Biosystems Human Organs-on-Chips Product Portfolio
- 8.5.5 Tara Biosystems Recent Developments
- 8.6 Draper Laboratory
- 8.6.1 Draper Laboratory Company Information
- 8.6.2 Draper Laboratory Business Overview
- 8.6.3 Draper Laboratory Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Draper Laboratory Human Organs-on-Chips Product Portfolio
- 8.6.5 Draper Laboratory Recent Developments
- 8.7 Mimetas
- 8.7.1 Mimetas Company Information
- 8.7.2 Mimetas Business Overview
- 8.7.3 Mimetas Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Mimetas Human Organs-on-Chips Product Portfolio
- 8.7.5 Mimetas Recent Developments
- 8.8 Nortis
- 8.8.1 Nortis Company Information
- 8.8.2 Nortis Business Overview
- 8.8.3 Nortis Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Nortis Human Organs-on-Chips Product Portfolio
- 8.8.5 Nortis Recent Developments
- 8.9 Micronit Microtechnologies B.V.
- 8.9.1 Micronit Microtechnologies B.V. Company Information
- 8.9.2 Micronit Microtechnologies B.V. Business Overview
- 8.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Product Portfolio
- 8.9.5 Micronit Microtechnologies B.V. Recent Developments
- 8.10 Kirkstall
- 8.10.1 Kirkstall Company Information
- 8.10.2 Kirkstall Business Overview
- 8.10.3 Kirkstall Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Kirkstall Human Organs-on-Chips Product Portfolio
- 8.10.5 Kirkstall Recent Developments
- 8.11 Cherry Biotech SAS
- 8.11.1 Cherry Biotech SAS Company Information
- 8.11.2 Cherry Biotech SAS Business Overview
- 8.11.3 Cherry Biotech SAS Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Cherry Biotech SAS Human Organs-on-Chips Product Portfolio
- 8.11.5 Cherry Biotech SAS Recent Developments
- 8.12 Else Kooi Laboratory
- 8.12.1 Else Kooi Laboratory Company Information
- 8.12.2 Else Kooi Laboratory Business Overview
- 8.12.3 Else Kooi Laboratory Human Organs-on-Chips Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Else Kooi Laboratory Human Organs-on-Chips Product Portfolio
- 8.12.5 Else Kooi Laboratory Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Human Organs-on-Chips Value Chain Analysis
- 9.1.1 Human Organs-on-Chips Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Human Organs-on-Chips Production Mode & Process
- 9.2 Human Organs-on-Chips Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Human Organs-on-Chips Distributors
- 9.2.3 Human Organs-on-Chips Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst